Product Code: GVR-4-68040-065-4
Direct-to-Consumer Genetic Testing Market Growth & Trends:
The global direct-to-consumer genetic testing market size is expected to reach USD 8.82 billion by 2030, registering a CAGR of 24.4% during the forecast period, according to a new report by Grand View Research, Inc. The major drivers of market growth include increasing awareness about the potential benefits of genetic testing, growing demand for personalized medicine, and decreasing the cost of genomic sequencing. Moreover, the number of companies offering direct-to-consumer (DTC) genetic testing services has increased, offering consumers a wider range of options.
The marketplace is moderately fragmented, with a large number of medium and large-sized companies accounting for the majority revenue of the market. These entities are undertaking various strategic initiatives to strengthen their marketplace presence. For instance, in August 2021, Ancestry declared that it acquired a leading French genealogy company, Geneanet.
The market has significantly grown in the past few years due to the growing interest of consumers and healthcare providers in personalized genetic analysis. This is majorly due to the growing concerns about sedentary lifestyle and poor diet-related illness among the global population. Companies are undertaking strategic initiatives to increase awareness among consumers about the benefits of genealogy examination. This, in turn, has developed DTC testing, one of the key applications of the consumer genomics field, to capture the wide interest of clinicians and customers.
Millions of users have used services provided by consumer genomics companies to learn about their ancestry, family tree, and risk of inherited disorders. DNA database of Ancestry DNA includes data of around three million people. Recently, AncestryDNA announced that it has sold more than 3.5 million DNA test kits, whereas its competitor 23andMe reported 1 million members. In addition, around 15% (nearly 2.5 million subscribers) of total DNA kit customers are Ancestry subscribers who pay around USD 20.0 for access to Ancestry's research data and tools per month.
The COVID-19 pandemic had a significant impact on the DTC genetic testing market. There was a notable demand for at-home genetic testing during the pandemic. However, the at-home segment declined as the pandemic withered.
Direct-to-Consumer Genetic Testing Market Report Highlights:
- Predictive testing dominated the test type segment in 2023, which is attributable to its accessibility and affordability
- The whole genome sequencing segment dominated the market in 2023, owing to its comprehensive analysis which offers a wide range of genetic information
- Online platforms dominated the market in terms of total revenue in 2023, since this method provides a convenient and accessible way for consumers to purchase genetic tests
- North America held the largest share of the market in 2023 which can be attributed to favorable regulatory environments, advanced healthcare infrastructure, and high consumer awareness along with adoption.
Table Of Contents
Chapter 1 Research Methodology & Scope
- 1.1 Market Segmentation and Scope
- 1.2 Market Definitions
- 1.2.1 Service
- 1.2.2 Formulation
- 1.2.3 Therapeutic Area
- 1.3 Research Methodology
- 1.4 Information Procurement
- 1.4.1 Information analysis
- 1.4.2 Market formulation & data visualization
- 1.4.3 Data validation & publishing
- 1.5 Research Scope and Assumptions
- 1.5.1 Commodity Flow Analysis
- 1.5.2 Top-down market estimation
- 1.5.3 Country-based segment share calculation
- 1.5.4 Multivariate analysis
- 1.5.5 DTC Genetic Testing Market: CAGR Calculation
- 1.6 List of Secondary Sources
- 1.7 Objectives
- 1.7.1 Objective - 1:
- 1.7.2 Objective - 2:
- 1.7.3 Objective - 3:
- 1.7.4 Objective - 4:
Chapter 2 Executive Summary
- 2.1 Market Snapshot
- 2.2 Segment Snapshot
- 2.3 Competitive Landscape Snapshot
Chapter 3 DTC Genetic Testing Market: Variables, Trends, & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent Market Outlook
- 3.1.2 Ancillary Market Outlook
- 3.2 Market Dynamics
- 3.2.1 Market Driver Impact Analysis
- 3.2.2 Market Restraint Impact Analysis
- 3.3 Industry Analysis
- 3.3.1 Porter's Five Forces Analysis
- 3.3.2 Pestel Analysis
- 3.4 COVID-19 Impact on DTC Genetic Testing Market
- 3.4.1 Activities By Market Players
- 3.4.2 Long-Term Changes In The Market
Chapter 4 DTC Genetic Testing Market: Test Type Estimates & Trend Analysis
- 4.1 DTC Genetic Testing Market by Test Type: Key Takeaways
- 4.2 Test type Movement Analysis & Market Share, 2023 & 2030
- 4.3 DTC Genetic Testing Market Estimates & Forecast, By Test Type (USD Million)
- 4.3.1 Nutrigenomics Testing
- 4.3.2 Predictive Testing
- 4.3.3 Carrier Testing
- 4.3.4 Others
Chapter 5 DTC Genetic Testing Market: Technology Estimates & Trend Analysis
- 5.1 DTC Genetic Testing Market by Technology: Key Takeaways
- 5.2 Technology Movement Analysis & Market Share, 2023 & 2030
- 5.3 DTC Genetic Testing Market Estimates & Forecast, By Technology (USD Million)
- 5.3.1 Whole Genome Sequencing
- 5.3.2 Single Nucleotide Polymorphism Chips
- 5.3.3 Targetes Analysis
- 5.3.4 Others
Chapter 6 DTC Genetic Testing Market: Distribution Channel Estimates & Trend Analysis
- 6.1 DTC Genetic Testing Market by distribution channel: Key Takeaways
- 6.2 Distribution Channel Movement Analysis & Market Share, 2023 & 2030
- 6.3 DTC Genetic Testing Market Estimates & Forecast, By distribution channel (USD Million)
- 6.3.1 Online Platform
- 6.3.2 OTC
Chapter 7 DTC Genetic Testing Market: Regional Analysis
- 7.1 DTC Genetic Testing Market: Regional Outlook
- 7.2 DTC Genetic Testing Market by Region: Key Takeaways
- 7.3 DTC Genetic Testing Market by Region: Key Takeaway
- 7.4 North America
- 7.4.1 North America DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.4.2 U.S.
- 7.4.2.1 Key Country Dynamics
- 7.4.2.2 Competitive Scenario
- 7.4.2.3 Prevalence Insights
- 7.4.2.4 Regulatory Framework
- 7.4.2.5 Reimbursement Structure
- 7.4.2.6 U.S. DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.4.3 Canada
- 7.4.3.1 Key Country Dynamics
- 7.4.3.2 Competitive Scenario
- 7.4.3.3 Prevalence Insights
- 7.4.3.4 Regulatory Framework
- 7.4.3.5 Reimbursement Structure
- 7.4.3.6 Canada DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5 Europe
- 7.5.1 Europe DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.2 UK
- 7.5.2.1 Key Country Dynamics
- 7.5.2.2 Competitive Scenario
- 7.5.2.3 Prevalence Insights
- 7.5.2.4 Regulatory Framework
- 7.5.2.5 Reimbursement Structure
- 7.5.2.6 UK DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.3 Germany
- 7.5.3.1 Key Country Dynamics
- 7.5.3.2 Competitive Scenario
- 7.5.3.3 Prevalence Insights
- 7.5.3.4 Regulatory Framework
- 7.5.3.5 Reimbursement Structure
- 7.5.3.6 Germany DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.4 France
- 7.5.4.1 Key Country Dynamics
- 7.5.4.2 Competitive Scenario
- 7.5.4.3 Prevalence Insights
- 7.5.4.4 Regulatory Framework
- 7.5.4.5 Reimbursement Structure
- 7.5.4.6 France DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.5 Italy
- 7.5.5.1 Key Country Dynamics
- 7.5.5.2 Competitive Scenario
- 7.5.5.3 Prevalence Insights
- 7.5.5.4 Regulatory Framework
- 7.5.5.5 Reimbursement Structure
- 7.5.5.6 Italy DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.6 Spain
- 7.5.6.1 Key Country Dynamics
- 7.5.6.2 Competitive Scenario
- 7.5.6.3 Prevalence Insights
- 7.5.6.4 Regulatory Framework
- 7.5.6.5 Reimbursement Structure
- 7.5.6.6 Spain DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.7 Denmark
- 7.5.7.1 Key Country Dynamics
- 7.5.7.2 Competitive Scenario
- 7.5.7.3 Prevalence Insights
- 7.5.7.4 Regulatory Framework
- 7.5.7.5 Reimbursement Structure
- 7.5.7.6 Denmark DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.8 Sweden
- 7.5.8.1 Key Country Dynamics
- 7.5.8.2 Competitive Scenario
- 7.5.8.3 Prevalence Insights
- 7.5.8.4 Regulatory Framework
- 7.5.8.5 Reimbursement Structure
- 7.5.8.6 Sweden DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.9 Norway
- 7.5.9.1 Key Country Dynamics
- 7.5.9.2 Competitive Scenario
- 7.5.9.3 Prevalence Insights
- 7.5.9.4 Regulatory Framework
- 7.5.9.5 Reimbursement Structure
- 7.5.9.6 Norway DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6 Asia Pacific
- 7.6.1 Asia Pacific DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.2 China
- 7.6.2.1 Key Country Dynamics
- 7.6.2.2 Competitive Scenario
- 7.6.2.3 Prevalence Insights
- 7.6.2.4 Regulatory Framework
- 7.6.2.5 Reimbursement Structure
- 7.6.2.6 China DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.3 India
- 7.6.3.1 Key Country Dynamics
- 7.6.3.2 Competitive Scenario
- 7.6.3.3 Prevalence Insights
- 7.6.3.4 Regulatory Framework
- 7.6.3.5 Reimbursement Structure
- 7.6.3.6 India DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.4 Japan
- 7.6.4.1 Key Country Dynamics
- 7.6.4.2 Competitive Scenario
- 7.6.4.3 Prevalence Insights
- 7.6.4.4 Regulatory Framework
- 7.6.4.5 Reimbursement Structure
- 7.6.4.6 Japan DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.5 Australia
- 7.6.5.1 Key Country Dynamics
- 7.6.5.2 Competitive Scenario
- 7.6.5.3 Prevalence Insights
- 7.6.5.4 Regulatory Framework
- 7.6.5.5 Reimbursement Structure
- 7.6.5.6 Australia DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.6 Thailand
- 7.6.6.1 Key Country Dynamics
- 7.6.6.2 Competitive Scenario
- 7.6.6.3 Prevalence Insights
- 7.6.6.4 Regulatory Framework
- 7.6.6.5 Reimbursement Structure
- 7.6.6.6 Thailand DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.7 South Korea
- 7.6.7.1 Key Country Dynamics
- 7.6.7.2 Competitive Scenario
- 7.6.7.3 Prevalence Insights
- 7.6.7.4 Regulatory Framework
- 7.6.7.5 Reimbursement Structure
- 7.6.7.6 South Korea DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.7 Latin America
- 7.7.1 Latin America DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.7.2 Brazil
- 7.7.2.1 Key Country Dynamics
- 7.7.2.2 Competitive Scenario
- 7.7.2.3 Prevalence Insights
- 7.7.2.4 Regulatory Framework
- 7.7.2.5 Reimbursement Structure
- 7.7.2.6 Brazil DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.7.3 Mexico
- 7.7.3.1 Key Country Dynamics
- 7.7.3.2 Competitive Scenario
- 7.7.3.3 Prevalence Insights
- 7.7.3.4 Regulatory Framework
- 7.7.3.5 Reimbursement Structure
- 7.7.3.6 Mexico DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.7.4 Argentina
- 7.7.4.1 Key Country Dynamics
- 7.7.4.2 Competitive Scenario
- 7.7.4.3 Prevalence Insights
- 7.7.4.4 Regulatory Framework
- 7.7.4.5 Reimbursement Structure
- 7.7.4.6 Argentina DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.8 Middle East & Africa
- 7.8.1 Middle East & Africa DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.8.2 South Africa
- 7.8.2.1 Key Country Dynamics
- 7.8.2.2 Competitive Scenario
- 7.8.2.3 Prevalence Insights
- 7.8.2.4 Regulatory Framework
- 7.8.2.5 Reimbursement Structure
- 7.8.2.6 South Africa DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.8.3 Saudi Arabia
- 7.8.3.1 Key Country Dynamics
- 7.8.3.2 Competitive Scenario
- 7.8.3.3 Prevalence Insights
- 7.8.3.4 Regulatory Framework
- 7.8.3.5 Reimbursement Structure
- 7.8.3.6 Saudi Arabia DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.8.4 UAE
- 7.8.4.1 Key Country Dynamics
- 7.8.4.2 Competitive Scenario
- 7.8.4.3 Prevalence Insights
- 7.8.4.4 Regulatory Framework
- 7.8.4.5 Reimbursement Structure
- 7.8.4.6 UAE DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.8.5 Kuwait
- 7.8.5.1 Key Country Dynamics
- 7.8.5.2 Competitive Scenario
- 7.8.5.3 Prevalence Insights
- 7.8.5.4 Regulatory Framework
- 7.8.5.5 Reimbursement Structure
- 7.8.5.6 Kuwait DTC Genetic Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 8 Competitive Landscape
- 8.1 Recent Developments & Impact Analysis, by Key Market Participants
- 8.1.1 Ansoff matrix
- 8.1.2 Heat map analysis
- 8.1.3 Major Deals and Strategic Alliances Analysis
- 8.1.3.1 Joint Ventures
- 8.1.3.2 Licensing Agreements
- 8.1.3.3 Product Launches
- 8.1.3.4 Conferences and Campaigns
- 8.2 Company Categorization
- 8.2.1 Innovators
- 8.2.2 Market Leaders
- 8.3 Vendor Landscape
- 8.3.1 List of key distributors and channel partners
- 8.3.2 Key customers
- 8.4 Public Companies
- 8.4.1 Competitive Dashboard Analysis
- 8.5 Private Companies
- 8.5.1 List of key emerging companies
- 8.6 Company Profiles
- 8.6.1 23andMe
- 8.6.1.1 Company overview
- 8.6.1.2 Financial performance
- 8.6.1.3 Product benchmarking
- 8.6.1.4 Strategic Initiatives
- 8.6.2 Illumina, Inc.
- 8.6.2.1 Company overview
- 8.6.2.2 Financial performance
- 8.6.2.3 Product benchmarking
- 8.6.2.4 Strategic Initiatives
- 8.6.3 Family Tree DNA
- 8.6.3.1 Company overview
- 8.6.3.2 Financial performance
- 8.6.3.3 Product benchmarking
- 8.6.3.4 Strategic Initiatives
- 8.6.4 Ancestry
- 8.6.4.1 Company overview
- 8.6.4.2 Financial performance
- 8.6.4.3 Product benchmarking
- 8.6.4.4 Strategic Initiatives
- 8.6.5 Myriad Genetics, Inc.
- 8.6.5.1 Company overview
- 8.6.5.2 Financial performance
- 8.6.5.3 Product benchmarking
- 8.6.5.4 Strategic Initiatives
- 8.6.6 Genesis HealthCare
- 8.6.6.1 Company overview
- 8.6.6.2 Financial performance
- 8.6.6.3 Product benchmarking
- 8.6.6.4 Strategic Initiatives
- 8.6.7 EasyDNA
- 8.6.7.1 Company overview
- 8.6.7.2 Financial performance
- 8.6.7.3 Product benchmarking
- 8.6.7.4 Strategic initiatives
- 8.6.8 Veritas
- 8.6.8.1 Company overview
- 8.6.8.2 Financial performance
- 8.6.8.3 Product benchmarking
- 8.6.8.4 Strategic initiatives
- 8.6.9 Full Genomes Corporation, Inc
- 8.6.9.1 Company overview
- 8.6.9.2 Financial performance
- 8.6.9.3 Product benchmarking
- 8.6.9.4 Strategic initiatives
- 8.6.10 Living DNA Ltd.
- 8.6.10.1 Company overview
- 8.6.10.2 Financial performance
- 8.6.10.3 Product benchmarking
- 8.6.10.4 Strategic initiatives
- 8.6.11 Color Health, Inc.
- 8.6.11.1 Company overview
- 8.6.11.2 Financial performance
- 8.6.11.3 Product benchmarking
- 8.6.11.4 Strategic initiatives